YaSheng Group
HERB · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.11 | 0.04 | 0.05 | 0.15 |
| FCF Yield | 19.80% | 28.15% | 2.46% | 14.03% |
| EV / EBITDA | 0.72 | 0.76 | 2.64 | 3.28 |
| Quality | ||||
| ROIC | 2.52% | 2.31% | 1.85% | 1.31% |
| Gross Margin | 33.46% | 33.31% | 30.06% | 28.64% |
| Cash Conversion Ratio | 0.68 | 0.54 | 0.45 | 0.66 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.11% | 14.68% | 13.99% | 17.31% |
| Free Cash Flow Growth | 0.67% | 583.05% | -79.46% | 318.44% |
| Safety | ||||
| Net Debt / EBITDA | -1.08 | -0.54 | -0.48 | -0.40 |
| Interest Coverage | 0.00 | 1,374.78 | 1,478.46 | 1,470.69 |
| Efficiency | ||||
| Inventory Turnover | 5.49 | 5.49 | 6.31 | 3.35 |
| Cash Conversion Cycle | 73.84 | 72.98 | 60.56 | 121.35 |